[ad_1] The recombinant BCG vaccine from the Serum Institute would be the first candidate vaccine in India to start human trials in the next two weeks. This is to test whether the BCG vaccine, administered at birth to Indians to combat tuberculosis, can also increase immunity in adults against the …
Read More »